Modeling and Integral X-Ray, Optical, and MRI Visualization of Multiorgan Metastases of Orthotopic 4T1 Breast Carcinoma in BALB/c Mice

Verfasser / Beitragende:
[V. Baklaushev, N. Grinenko, G. Yusubalieva, M. Abakumov, I. Gubskii, S. Cherepanov, I. Kashparov, M. Burenkov, E. Rabinovich, N. Ivanova, O. Antonova, V. Chekhonin]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 158/4(2015-02-01), 581-588
Format:
Artikel (online)
ID: 605538093
LEADER caa a22 4500
001 605538093
003 CHVBK
005 20210128100900.0
007 cr unu---uuuuu
008 210128e20150201xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2810-3  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2810-3 
245 0 0 |a Modeling and Integral X-Ray, Optical, and MRI Visualization of Multiorgan Metastases of Orthotopic 4T1 Breast Carcinoma in BALB/c Mice  |h [Elektronische Daten]  |c [V. Baklaushev, N. Grinenko, G. Yusubalieva, M. Abakumov, I. Gubskii, S. Cherepanov, I. Kashparov, M. Burenkov, E. Rabinovich, N. Ivanova, O. Antonova, V. Chekhonin] 
520 3 |a A model of highly metastasizing orthotopic allogeneic breast carcinoma was reproduced and standardized in experiments on BALB/c mice. 4T1 cells characterized by high metastatic activity were transfected with red fluorescent protein (RFP) gene or firefly luciferase (Luc2) gene. Unmodified 4T1 cells and modified 4T1-RFP and 4T1-Luc2 cells were subcutaneously injected to mature female mice into the second mammary fat pads. Quantitative evaluation of the primary node and visceral metastases was performed using magnetic-resonance imaging, X-ray and optical tomography. Modification of 4T1 cells with RFP gene considerably reduced their invasive and metastatic potential and led to spontaneous regression of the primary tumor in 20% cases. Modification of 4T1 cells with Luc2 gene had practically no effect on proliferative, invasive, and metastatic characteristics of the tumor and provided the possibility of quantitative analysis of the primary tumor dynamics by the luminescence intensity. The survival median in mice receiving unmodified 4T1 cells and transfected 4T1-RFP and 4Т1-Luc2 cells was 32, 42, and 38 days, respectively. Neither primary node nor tumor metastases accumulated gadolinium-containing contrast agent and Alasens fluorescent tracer. After implantation of 4T1 and 4Т1-Luc2 cells, multiple metastases were more often detected in the lungs, liver, spleen, spine, and regional lymph nodes and less frequently in the brain, which corresponded to metastasizing profile of human breast cancer. The developed model of orthotopic breast carcinoma 4T1 in BALB/c mice with complex detection of multiple organ metastases using X-ray microCT, optical, and MRI can be recommended for preclinical studies of new antitumor preparations. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a 4T1 breast carcinoma  |2 nationallicence 
690 7 |a multiple organ metastases  |2 nationallicence 
690 7 |a optical tomography  |2 nationallicence 
690 7 |a microCT  |2 nationallicence 
690 7 |a magnetic-resonance imaging  |2 nationallicence 
700 1 |a Baklaushev  |D V.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
700 1 |a Grinenko  |D N.  |u Department of Fundamental and Applied Neurobiology, V. P. Serbskii State Research Center of Forensic and Social Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia  |4 aut 
700 1 |a Yusubalieva  |D G.  |u Department of Fundamental and Applied Neurobiology, V. P. Serbskii State Research Center of Forensic and Social Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia  |4 aut 
700 1 |a Abakumov  |D M.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
700 1 |a Gubskii  |D I.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
700 1 |a Cherepanov  |D S.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
700 1 |a Kashparov  |D I.  |u Institute of Protein Research, Russian Academy of Sciences, Moscow, Russia  |4 aut 
700 1 |a Burenkov  |D M.  |u Farm-Sintez Company, Moscow, Russia  |4 aut 
700 1 |a Rabinovich  |D E.  |u Farm-Sintez Company, Moscow, Russia  |4 aut 
700 1 |a Ivanova  |D N.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
700 1 |a Antonova  |D O.  |u Department of Fundamental and Applied Neurobiology, V. P. Serbskii State Research Center of Forensic and Social Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia  |4 aut 
700 1 |a Chekhonin  |D V.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/4(2015-02-01), 581-588  |x 0007-4888  |q 158:4<581  |1 2015  |2 158  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2810-3  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2810-3  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Baklaushev  |D V.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Grinenko  |D N.  |u Department of Fundamental and Applied Neurobiology, V. P. Serbskii State Research Center of Forensic and Social Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yusubalieva  |D G.  |u Department of Fundamental and Applied Neurobiology, V. P. Serbskii State Research Center of Forensic and Social Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Abakumov  |D M.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gubskii  |D I.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cherepanov  |D S.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kashparov  |D I.  |u Institute of Protein Research, Russian Academy of Sciences, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Burenkov  |D M.  |u Farm-Sintez Company, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Rabinovich  |D E.  |u Farm-Sintez Company, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ivanova  |D N.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Antonova  |D O.  |u Department of Fundamental and Applied Neurobiology, V. P. Serbskii State Research Center of Forensic and Social Psychiatry, Ministry of Health of the Russian Federation, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chekhonin  |D V.  |u Research and Education Center Medical Nanobiotechnologies, Russian State Medical University, Moscow, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/4(2015-02-01), 581-588  |x 0007-4888  |q 158:4<581  |1 2015  |2 158  |o 10517